Franklin Resources
EIKN icon

Franklin Resources’s Eikon Therapeutics EIKN Stock Holding History

Franklin Resources’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.24M Hold
350,000
– – ﹤0.01% 2000
2026
Q2 		$4.57M Hold
350,000
– – ﹤0.01% 1646
2026
Q1 		$3.7M Buy
+350,000
New +$4.68M ﹤0.01% 1657

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Merck & Co
Merck & Co Rahway, New Jersey $820M AUM 395.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SCM
Soros Capital Management New York $182M AUM 108.83% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

Franklin Resources's EIKN Position: Q3 2026 in Review

Franklin Resources held its Eikon Therapeutics (EIKN) position steady in Q3 2026 at 350,000 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Franklin Resources first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.57M in Q2 2026. 63 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Franklin Resources held 350,000 shares of Eikon Therapeutics worth $2.24M as of Q3 2026.
  • Franklin Resources left its Eikon Therapeutics share count unchanged in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #2000 holding.
  • Franklin Resources first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Franklin Resources's Eikon Therapeutics position peaked at $4.57M in Q2 2026.
  • 63 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.